Carbon Brand Solutions had a fantastic time in Busan, South Korea for The International Diabetes Federation (IDF) Congress. New therapies and cutting-edge research into type 1 and 2 diabetes was presented and we were fortunate enough to catch up with the presenters, our editorial board members and other leading experts in the field of diabetes.
Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease, with a worldwide prevalence of approximately 25%.
Atherosclerosis (ATH) and ATH-related diseases represent the leading cause of disability and mortality in the Western world.
It is estimated that nearly 1.5 billion adults in the world will have hypertension in the decade ahead.
The European Society of Cardiology (ESC) guidelines on the management of ventricular arrhythmias and prevention on SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD.
